Daniels, M. ; Fischer-Posovszky, P.* ; Boschmann, M.* ; Jumpertz von Schwartzenberg, R. ; Müller, T.D. ; Sandforth, L. ; Frank-Podlech, S. ; Hülskämper, S. ; Peter, A. ; Wabitsch, M.* ; Jordan, J.* ; Birkenfeld, A.L.
Atrial natriuretic peptide and leptin interactions in healthy men.
Front. Endocrin. 14:1195677 (2023)
INTRODUCTION: Atrial natriuretic peptide (ANP), a hormone secreted from the heart, controls cardiovascular and renal functions including arterial blood pressure and natriuresis. ANP also exerts metabolic effects in adipose tissue, liver and skeletal muscle, and interacts with the secretion of adipokines. We tested the hypothesis that ANP lowers concentrations of the anorexigenic adipokine leptin in healthy humans in vivo. METHODS: Human ANP or matching placebo was infused intravenously (iv) into healthy men in a controlled clinical trial. RESULTS: Within 135 minutes of iv ANP infusion, we observed an acute decrease in plasma leptin levels compared to controls. Free fatty acids markedly increased with ANP infusion in vivo, indicating activated lipolysis. In human SGBS adipocytes, ANP suppressed leptin release. DISCUSSION: The study shows that the cardiac hormone ANP reduces the levels of the anorexigenic adipokine leptin in healthy humans, providing further support for ANP as a cardiomyokine in a heart - adipose tissue axis. (registered in the German Clinical Trials Register and the WHO International Clinical Trials Registry Platform was granted under DRKS00024559).
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Anp ; Atrial Natriuretic Peptide ; Heart Failure ; Insulin Resistance ; Leptin ; Lipolysis ; Obesity; Secretion; Capacity
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
1664-2392
e-ISSN
1664-2392
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 14,
Issue: ,
Pages: ,
Article Number: 1195677
Supplement: ,
Series
Publisher
Frontiers
Publishing Place
Lausanne
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502400-001
G-501900-221
Grants
Helmholtz Association by a Helmholtz Young Investigator Group
German Center for Diabetes Research (DZD)
German Research Foundation
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2023-10-06